These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
493 related articles for article (PubMed ID: 23181594)
1. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma. Morton CA; Szeimies RM; Sidoroff A; Braathen LR J Eur Acad Dermatol Venereol; 2013 May; 27(5):536-44. PubMed ID: 23181594 [TBL] [Abstract][Full Text] [Related]
2. European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen's disease and basal cell carcinomas. Morton CA; Szeimies RM; Basset-Seguin N; Calzavara-Pinton P; Gilaberte Y; Haedersdal M; Hofbauer GFL; Hunger RE; Karrer S; Piaserico S; Ulrich C; Wennberg AM; Braathen LR J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):2225-2238. PubMed ID: 31779042 [TBL] [Abstract][Full Text] [Related]
3. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients. Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909 [TBL] [Abstract][Full Text] [Related]
4. A synthesis of the world's guidelines on photodynamic therapy for non-melanoma skin cancer. Morton CA G Ital Dermatol Venereol; 2018 Dec; 153(6):783-792. PubMed ID: 29417799 [TBL] [Abstract][Full Text] [Related]
5. European guidelines for topical PDT part 1 JEADV 2013; 27: 536-544. Skaria AM J Eur Acad Dermatol Venereol; 2014 May; 28(5):673. PubMed ID: 23981061 [No Abstract] [Full Text] [Related]
7. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up. Farhi D; Bedane C; Savary J; Basset-Seguin N Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280 [TBL] [Abstract][Full Text] [Related]
8. Response to Letter to the editor: 'European guidelines for topical PDT part 1. JEADV 2013;27:536-544' DOI: 10.1111/jdv.12258. Morton CA; Szeimies RM; Sidoroff A; Braathen LR J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1451-2. PubMed ID: 24666245 [No Abstract] [Full Text] [Related]
9. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments? Morton CA J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514 [TBL] [Abstract][Full Text] [Related]
11. [PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology]. Basset-Seguin N Ann Dermatol Venereol; 2013 Nov; 140 Suppl 2():223-8. PubMed ID: 24199714 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma. Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215 [TBL] [Abstract][Full Text] [Related]
13. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light]. Harth Y; Hirshovitz B Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421 [TBL] [Abstract][Full Text] [Related]